Australian Gonococcal Surveillance Program, 1 October to 31 December 2025
Monica Lahra1, Siobhan Hurley2, Sebastiaan Van Hal3
1NSW Health Pathology, The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW 2052, Australia. monica.lahra@health.nsw.gov.au.
None:
The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on antimicrobial susceptibility testing to an agreed group of antimicrobial agents for the Australian Gonococcal Surveillance Programme (AGSP). The AGSP data are presented quarterly in tabulated form, as well as in the AGSP annual report. This report presents national gonococcal antimicrobial resistance surveillance data from 1 October to 31 December 2025.
Related Concept Videos
Principles of Disease Surveillance
Streptococcal Pharyngitis
Sexually Transmitted Infections
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Acute Pyelonephritis II: Diagnostic Studies and Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

